Assignee
RA PHARMACEUTICALS INC
US·24 granted patents·9 pending applications·108 citations·filing 2013–2024
Top patents by PatentIndex Score
33 records- 0197US10435438B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Oct 8, 2019·12 cites·21 claims
- 0297US10106579B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·19 cites·20 claims
- 0396US10208089B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·12 cites·21 claims
- 0495US10328115B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·15 cites·22 claims
- 0594US11014965B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted May 25, 2021·3 cites·18 claims
- 0694US10588936B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Mar 17, 2020·13 cites·20 claims
- 0794US9937222B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·14 cites·15 claims
- 0891US11752190B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted Sep 12, 2023·2 cites·18 claims
- 0991US10918691B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·2 cites·21 claims
- 1089US11123399B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2017·Granted Sep 21, 2021·4 cites·15 claims
- 1188US10835574B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2016·Granted Nov 17, 2020·7 cites·33 claims
- 1287US12239684B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·0 cites·13 claims
- 1384US9238676B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2013·Granted Jan 19, 2016·2 cites·20 claims
- 1482US11535650B1Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2022·Granted Dec 27, 2022·0 cites·2 claims
- 1582US10272132B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2018·Granted Apr 30, 2019·1 cites·20 claims
- 1680US10562934B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Feb 18, 2020·0 cites·7 claims
- 1778US11965040B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Apr 23, 2024·0 cites·12 claims
- 1875US11707503B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·0 cites·20 claims
- 1975US9644004B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·1 cites·20 claims
- 2075US2025090624A1Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2174US10954287B2Ras binding peptides and methods of useRA PHARMACEUTICALS INC·Filed 2017·Granted Mar 23, 2021·1 cites·22 claims
- 2271US11723949B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Aug 15, 2023·0 cites·16 claims
- 2365US2025032574A1Neurological disease treatment with zilucoplanRA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2464US9999650B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2017·Granted Jun 19, 2018·0 cites·25 claims
- 2554US11814445B2Cyclic polypeptides for PCSK9 inhibitionRA PHARMACEUTICALS INC·Filed 2019·Granted Nov 14, 2023·0 cites·15 claims
- 2651US2022211799A1Compositions and methods for modulating complement activityRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2751US2022133841A1Neurological disease treatment with zilucoplanRA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2850US2022370548A1Neurological disease treatment with complement inhibitorsRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2948US2023115176A1Complement Modulators and Related MethodsRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3046US2020282024A1Formulations for compound deliveryRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3145US2022160820A1Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3243US11814444B2Cyclic polypeptides for PCSK9 inhibitionRA PHARMACEUTICALS INC·Filed 2019·Granted Nov 14, 2023·0 cites·25 claims
- 3342US2021000927A1Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →